Parallax Volatility Advisers
FLNA

Parallax Volatility Advisers’s Filana Therapeutics FLNA Stock Holding History

Parallax Volatility Advisers’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-74,100
Closed -$2.19M – 3129
2022
Q4 		$2.19M Hold
74,100
– – ﹤0.01% 1365
2022
Q3 		$3.1M Buy
74,100
+7,600
+11% +$205K ﹤0.01% 1214
2022
Q2 		$1.87M Buy
+66,500
New +$1.68M ﹤0.01% 1379

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Parallax Volatility Advisers's FLNA Position: Q3 2023 in Review

Parallax Volatility Advisers sold out of Filana Therapeutics (FLNA) in Q3 2023, closing a stake of 8,490 shares — an estimated $168K sold.

Parallax Volatility Advisers first reported a position in FLNA in Q3 2022 and held it in 4 quarters. The position peaked at $1.19M in Q3 2022. 140 funds tracked by Wall St. Rank hold FLNA as of Q3 2023.

  • Parallax Volatility Advisers reported no remaining Filana Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Parallax Volatility Advisers sold 8,490 Filana Therapeutics shares in Q3 2023, an estimated $168K.
  • Parallax Volatility Advisers first reported a position in Filana Therapeutics in Q3 2022 and held it in 4 quarters.
  • Parallax Volatility Advisers's Filana Therapeutics position peaked at $1.19M in Q3 2022.
  • 140 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2023.

Based on Parallax Volatility Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.